IBDEI0Z7 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15890,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,15890,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,15890,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,15891,0)
 ;;=L27.0^^61^765^305
 ;;^UTILITY(U,$J,358.3,15891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15891,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,15891,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,15891,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,15892,0)
 ;;=L27.1^^61^765^306
 ;;^UTILITY(U,$J,358.3,15892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15892,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,15892,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,15892,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,15893,0)
 ;;=L29.0^^61^765^290
 ;;^UTILITY(U,$J,358.3,15893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15893,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,15893,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,15893,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,15894,0)
 ;;=L29.9^^61^765^291
 ;;^UTILITY(U,$J,358.3,15894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15894,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,15894,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,15894,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,15895,0)
 ;;=L30.0^^61^765^270
 ;;^UTILITY(U,$J,358.3,15895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15895,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,15895,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,15895,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,15896,0)
 ;;=L30.1^^61^765^143
 ;;^UTILITY(U,$J,358.3,15896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15896,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,15896,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,15896,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,15897,0)
 ;;=L30.2^^61^765^135
 ;;^UTILITY(U,$J,358.3,15897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15897,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,15897,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,15897,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,15898,0)
 ;;=L30.4^^61^765^147
 ;;^UTILITY(U,$J,358.3,15898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15898,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,15898,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,15898,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,15899,0)
 ;;=L30.8^^61^765^138
 ;;^UTILITY(U,$J,358.3,15899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15899,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,15899,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,15899,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,15900,0)
 ;;=L30.9^^61^765^139
 ;;^UTILITY(U,$J,358.3,15900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15900,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,15900,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,15900,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,15901,0)
 ;;=L40.0^^61^765^293
 ;;^UTILITY(U,$J,358.3,15901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15901,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,15901,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,15901,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,15902,0)
 ;;=L40.1^^61^765^296
 ;;^UTILITY(U,$J,358.3,15902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15902,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,15902,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,15902,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,15903,0)
 ;;=L40.2^^61^765^12
